MC
AVNR

Menta Capital’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Menta Capital’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-27,400
Closed -$464K – 889
2014
Q4 		$464K Buy
+27,400
New +$385K 0.07% 447

Menta Capital's AVNR Position: Q1 2015 in Review

Menta Capital sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 27,400 shares — an estimated $464K sold.

Menta Capital first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $464K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Menta Capital reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Menta Capital sold 27,400 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $464K.
  • Menta Capital first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
  • Menta Capital's AVANIR PHARMACEUTICALS, INC CL A position peaked at $464K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Menta Capital's 13F filing for Q1 2015, filed 24 Apr 2015.